Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
2016 · The Lancet. Gastroenterology & hepatology · 2,006 citations
https://doi.org/10.1016/s2468-1253(16)30181-9
C
Colm Bergin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
285
Papers
10.1K
Citations
46
h-index
122
i10-index
Colm Bergin is an academic researcher from Ollscoil na Gaillimhe – University of Galway. The author has contributed to research in topics: COVID-19 Clinical Research Studies & Hepatitis C virus research & HIV/AIDS Research and Interventions. The author has an h-index of 46, co-authored 243 publications.
ORCID: 0000-0002-6651-1132Papers by this author
worksCare of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
2002 · AIDS · 443 citations
https://doi.org/10.1097/00002030-200204120-00001
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
2022 · The Lancet · 395 citations
https://doi.org/10.1016/s0140-6736(22)00519-0
Persistent endotheliopathy in the pathogenesis of long COVID syndrome
2021 · Journal of Thrombosis and Haemostasis · 327 citations
https://doi.org/10.1111/jth.15490
Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial
2021 · The Lancet HIV · 88 citations
https://doi.org/10.1016/s2352-3018(21)00071-0
ADAMTS13 regulation of VWF multimer distribution in severe COVID‐19
2021 · Journal of Thrombosis and Haemostasis · 76 citations
https://doi.org/10.1111/jth.15409
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat